Abstract
Meningococcal disease has been a worldwide problem for many centuries. The meningococcus, Neisseria meningitidis, first described by Weichselbaum in 1887, is a gram-negative, kidney-bean-shaped organism found both intraand extracellularly.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amato Neto, V., Finger, H., Gotschlich, E.C, Feldman, R.A., Avila, C.A. de, Konicki, S.R., and Laus, W.C., 1974, Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children, Rev. Inst. Med. Trop. Sao Paulo 16:149–153.
Ammann, A.J., Addiego, J., Wara, D.W., Lubin, B., Smith, W.B., and Mentzer, W.C., 1977, Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy, N. Engl. J. Med. 297:897–900.
Anderson, P., and Smith, D.H., 1977, Immunogenicity in weanling rabbits of a polyribophosphate complex from Haemophilus influenzae Type b, J. Infect. Dis. 136:S63–S70.
Apicella, M.A., 1974, Identification of a subgroup antigen on the Neisseria meningitidis group C capsular Polysaccharide, J. Infect. Dis. 129:147–153.
Artenstein, M.S., 1971, Meningococcal infections. 5. Duration of Polysaccharide-vaccine-induced antibody. Bull. WHO 45:291–293.
Artenstein, M.S., and Brandt, B.L., 1975, Immunologic hyporesponsiveness in man to group C meningococcal Polysaccharide, J. Immunol. 115:5–7.
Artenstein, M.S., Rust, J.H., Hunter, D.H., Lamson, T.H., and Buescher, E.L., 1967, Acute respiratory disease and meningococcal infection in Army recruits, JAMA 201:1004–1008.
Artenstein, M.S., Gold, R., Zimmerly, J.G., Wyle, F.A., Branche, W.C., Jr., and Harkins, C., 1970a, Cutaneous reactions and antibody responses to meningococcal group C vaccines in man, J. Infect. Dis. 121:372–377.
Artenstein, M.S., Gold, R., Zimmerly, J.G., Wyle, F., Schneider, H., and Harkin, C., 1970b, Prevention of meningococcal disease by group C Polysaccharide vaccine, N. Engl. J. Med. 282:417–420.
Artenstein, M.S., Schneider, H., and Tingley, M.D., 1971a, Meningococcal infections. 1. Prevalence of serogroups causing disease in U.S. Army personnel in 1964–1970, Bull. WHO 45:275–278.
Artenstein, M.S., Branche, W.C., Jr., Zimmerly, J.G., Cohen, R.L., Tramont, E.C., Kasper, D.L., and Harkins, C, 1971b, Meningococcal infections. 3. Studies of the group A Polysaccharide vaccines, Bull. WHO 45:283–286.
Artenstein, M.S., Brandt, B.L., Tramont, E.C., Branche, W.C., Jr., Fleet, H.D., and Cohen, R.L., 1971c, Serologie studies of meningococcal infection and Polysaccharide vaccination, J. Infect. Dis. 124:277–288.
Artenstein, M.S., Winter, P.E., Gold, R., and Smith, C.D., 1974, Immunoprophylaxis of meningococcal infection, Milit. Med. 139:91–95.
Baltimore, R.S., and Hammerschlag, M., 1977, Meningococcal bacteremia — Clinical and serologie studies of infants with mild illness, Am. J. Dis. Child. 131:1001–1004.
Bertram, M.A., Griffiss, J.M., and Brand, D.D., 1976, Response to antigenic determinants on Neisseria meningitidis lipopolysaccharide investigated with a new radioactive antigen-binding assay, J. Immunol. 116:842–846.
Bhattacharjee, A.K., Jennings, H.J., and Kenny, C.P., 1974, Characterization of 3-deoxy-D-manno octulosonic acid as a component of the capsular Polysaccharide antigen from Neisseria meningitidis serogroup 29E, Biochem. Biophys. Res. Commun. 61:489–493.
Bhattacharjee, A.K., Jennings, H.J., Kenny, C.P., Martin, A., and Smith, I.C.P., 1975, Structural determinations of the sialic acid Polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance, J. Biol. Chem. 250:1926–1932.
Bhattacharjee, A.K., Jennings, H.J., Kenny, C.P., Martin, A., and Smith I.C.P., 1976, Structural determination of the Polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO, Can. J. Biochem. 54:1–8.
Brandt, B.L., and Artenstein, M.S., 1975, Duration of antibody responses after immunization with Group C Neisseria meningitidis Polysaccharide, J. Infect. Dis. 131:S69–S75.
Brandt, B.L., Wyle, F.A., and Artenstein, M.S., 1972, A radioactive antigen-binding assay for Neisseria meningitidis Polysaccharide antibody, J. Immunol. 108:913–920.
Branham, S.E., 1956, Milestones in the history of the meningococcus, Can. J. Microsec. 2:175–188.
Bundle, D.R., Smith, I.C.P., and Jennings, H.J., 1974, Determination of the structure and conformation of bacterial Polysaccharides by C13 nuclear magnetic resonance: Studies on the group-specific antigens of Neisseria meningitis serogroups A and X, J. Biol. Chem. 249:2275–2281.
Carvalho, A., Giampaglia, C., Kimura, H., Pereira, O., Farhat, C., Neves, J., Prandini, R., Carvalho, E., and Zarvos, A.M., 1977, Maternal and infant antibody response to meningococcal vaccination in pregnancy, Lancet 2:809–811.
Chilcote, R.R., Baehner, R.L., and Hammond, D., 1976, Septicemia and meningitis in children splenectomized for Hodgkin’s disease, N. Engl. J. Med. 295:798–800.
Davis, C.E., and Arnold, K., 1974, Role of meningococcal endotoxin in meningococcal purpura, J. Exp. Med. 140:159–171.
DeMorais, J.S., Munford, R.S., Risi, J.B., Antezana, E., and Feldman, R.A., 1974, Epidemic disease due to serogroup C Neisseria meningtidis in Sao Paolo, Brazil, J. Infect. Dis. 129:568–571.
Devine, L.F., Pierce, W.E., Floyd, T.M., Rhode, S.L., Edwards, E.A., Siess, E.E., and Peckingpaugh, R.O., 1970, Evaluation of group C meningococcal Polysaccharide vaccine in marine recruits, San Diego, California, Am. J. Epidemiol. 92:25–32.
Dickerman, J.D., 1976, Bacterial infection and the asplenic host: A review, J. Trauma 16:662–668.
Eickhoff, T.C., 1971, Sero-epidemiologic studies of meningococcal infections with the indirect hemagglutination test, J. Infect. Dis. 123:519–526.
Eraklis, A.J., and Filler, R.M., 1972, Splenectomy in childhood: A review of 1413 cases, J. Pediatr. Surg. 7:382–388.
Erwa, H.H., Satti, M.H., and Abbas, A.M., 1971, Cerebrospinal meningitis in the Sudan, Sudan Notes Rec. 52:101–109.
Erwa, H.H., Haseeb, M.A., Idris, A.A., Lapeyssonie, L., Sanborn, W.R., and Sippel, J.E., 1973, A serogroup A meningococcal Polysaccharide vaccine, Bull. WHO 49:301–305.
Evans-Jones, L.G., Whittle, H.C., Onyewotu, I.L, Egler, L.J., and Greenwood, B.M., 1977, Comparative study of group A and group C meningococcal infection, Arch. Dis. Child. 52:320–323.
Farquhar, J.D., Hankens, W.A., DeSanctis, A.N., DeMeio, J.L., and Metzgar, D.P., 1977, Clinical and serological evaluation of purified Polysaccharide vaccines prepared from Neisseria meningitidis group Y (39828), Proc. Soc. Exp. Biol. Med. 155:453–455.
Fass, R.J., and Saslaw, S., 1972, Chronic meningococcemia: Possible pathogenic role of IgM deficiency, Arch. Intern. Med. 130:943–946.
Feldman, R.A., Koehler, R.E., and Fraser, D.W., 1976, Race-specific differences in bacterial meningitis death rates in the United States 1962–1968, Am. J. Publ. Health 66:392–396.
Flexner, S., 1913, The results of the serum treatment in 1300 cases of epidemic meningitis, J. Exp. Med. 17:553–576.
Frasch, C.E., 1977, Role of protein serotype antigens in protection against disease due to Neisseria meningitidis, J. Infect. Dis. 136:S84–S90.
Frasch, C.E., and Chapman, S.S., 1972a, Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbacterial method, Infect. Immun. 5:98–102.
Frasch, C.E., and Chapman, S.S., 1972b, Classification of Neisseria group B into distinct serotypes. II. Extraction of type-specific antigens for serotyping by precipitin techniques, Infect. Immunol. 6:127–133.
Frasch, C.E., and Chapman, S.S., 1973, Classification of Neisseria meningitidis group B into distinct serotypes. III. Application of a new bactericidal inhibition technique to distribution of serotypes among cases and carriers, J. Infect. Dis. 127:149–154.
Frasch, C.E., and Gotschlich, E.C., 1974, An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity, J. Exp. Med. 140:87–104.
Frasch, C.E., McNelis, R.M., and Gotschlich, E.C., 1976, Strain specific variation in the protein and lipopolysaccharide composition of the group B meningococcal outer membrane, J. Bacteriol. 127:973–981.
Fraser, D.W., Darby, C.P., Koehler, R.E., Jacobs, C.F., and Feldman, R.A., 1973, Risk factors in bacterial meningitis: Charleston County, South Carolina, J. Infect. Dis. 127:271–277.
Gavrilis, P., Rothenberg, S.P., and Guy, R., 1974, Correlation of low serum IgM levels with absence of functional splenic tissue in sickle cell disease syndromes, Am. J. Med. 57:542–545.
Gold, R., and Artenstein, M.S., 1971, Meningococcal infections. 2. Field trial of group C meningoccocal Polysaccharide vaccine in 1969–70, Bull WHO 45:279–282.
Gold, R., and Lepow, M.L., 1976, Present status of Polysaccharide vaccines in the prevention of meningococcal disease, Adv. Pediatr. 23:71–93.
Gold, R., and McLean, R. H., 1978, Absence of the sixth component of complement in a child with chronic meningococcemia, Pediatr. Res. 12:480 (abstr.).
Gold, R., and Wyle, F.A., 1970, New classification of N. meningiditis by means of bactericidal reactions, Infect. Immun. 1:479–484.
Gold, R., Winklehake, J.L., Mars, R.S., and Artenstein, M.S., 1971, Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping, J. Infect. Dis. 124:593–597.
Gold, R., Lepow, M.L., Goldschneider, I., Draper, T.L., and Gotschlich, E.C., 1976, Clinical evaluation of group A and group C meningococcal Polysaccharide vaccines in infants, J. Clin. Invest. 56:1536–1547.
Gold, R., Lepow, M.L., Goldschneider, I., Gotschlich, E.C, DeSanctis, A.N., and Metzgar, D.P., 1977a, Immunogenicity of groups A and C meningococcal polysaccharides of differing molecular weights, Pediatr. Res. 11:500.
Gold, R., Lepow, M.L., Goldschneider, I., and Gotschlich, E.C., 1977b, Immune response of human infants to Polysaccharide vaccines of groups A and C Neisseria meningitidis, J. Infect. Dis. 136:S31–S35.
Gold, R., Goldschneider, I., Lepow, M.L., Draper, T.F., and Randolph, M., 1978a, Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children, J. Infect. Dis. 137:112–121.
Gold, R., Lepow, M.L., Goldschneider, I., and Gotschlich, E.C., 1978b, Antibody responses of human infants to 3 doses of group A meningococcal Polysaccharide vaccine administered at 3, 4 and 6 months of age, J. Infect. Dis. 138:731–735.
Gold, R., Lepow, M. L., and Randolph, M., 1978c, Natural immunity to pyogenic bacteria, Pediatr. Res. 12:492 (abstr.).
Goldschneider, I., Gotschlich, E.C., and Artenstein, M.S., 1969a, Human immunity to the meningococcus. I. Role of humoral antibodies, J. Exp. Med. 129:1307–1326.
Goldschneider, I., Gotschlich, E.C., and Artenstein, M.S., 1969b, Human immunity to the meningococcus. II. Development of natural immunity, J. Exp. Med 129:1327–1348.
Goldschneider, I., Lepow, M.L., and Gotschlich, E.C., 1972, Immunogenicity of the group A and group C meningococcal Polysaccharides in children, J. Infect. Dis. 125:509–519.
Goldschneider, I., Lepow, M.L., Gotschlich, C., Mauck, F.T., Bachl, F., and Randolph, M., 1973, Immunogenicity of group A and group C meningococcal Polysaccharides in human infants, J. Infect. Dis. 128:769–776.
Gotschlich, E.C., 1975, Development of Polysaccharide vaccines for the prevention of meningococcal diseases, Monogr. Allergy 9:245–248.
Gotschlich, E.C., Liu, T.Y., and Artenstein, M.S., 1969a, Human immunity to the meningococcus. III. Preparation and immunochemical properties of the group A, group B and group C meningococcal Polysaccharides, J. Exp. Med. 129:1349–1365.
Gotschlich, E.C., Goldschneider, I., and Artenstein, M.S., 1969b, Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal Polysaccharides in human volunteers, J. Exp. Med. 129:1367–1384.
Gotschlich, E.C., Goldschneider, I., and Artenstein, M.S., 1969c, Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C Polysaccharide on the carrier state, J. Exp. Med. 129:1385–1395.
Gotschlich, E.C., Rey, M., Triau, R., and Sparks, K.J., 1972, Quantitative determination of the human immune response to immunization with meningococcal vaccines, J. Clin. Invest 51:89–96.
Gotschlich, E. C., Goldschneider, I., Lepow, M. L., and Gold, R., 1976, Immune response to bacterial Polysaccharides in man, in: Antibodies in Human Diagnosis and Therapy (E. Habar and R. M. Krause, ed.), pp. 391–403, Raven Press, New York.
Greenwood, B.M., Whittle, H.C., and Bryceson, A.D.M., 1973, Allergic complications of meningococcal disease. II. Immunological investigations, Br. Med. J. 2:737–740.
Griffiss, J.M., Broud, D.M., Silver, C.A., and Artenstein, M.S., 1977, Immunoepidemiology of meningococcal disease in military recruits. I. A model for serogroup independency of epidemic potential as determined by serotyping, J. Infect. Dis. 136:176–186.
Hobbs, J.R., Milner, R.D.G., and Watt, P.J., 1967, Gamma-M deficiency predisposing to meningococcal septicaemia, Br. Med. J. 4:583–586.
Johnston, R.B., Jr., Newman, S.L., and Struth, A.G., 1973, An abnormality of the alternative pathway of complement activation in sickle cell disease, N. Engl. J. Med. 288:803–808.
Kabat, E.A., and Bezer, A.E., 1958, The effect of variation in molecular weight in the antigenicity of dextran in man, Arch. Biochem. Biophys. 78:306–318.
Kabat, E.A., Kaiser, H., and Sikorski, H., 1944, Preparation of type-specific Polysaccharide of the type 1 meningococcus and a study of its effectiveness as an antigen in human beings, J. Exp. Med. 80:299–307.
Kasper, D.L., Winkelhake, J.L., Brandt, B.L., and Artenstein, M.S., 1973, Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitides, J. Infect. Dis. 127:378–387.
Kuronen, T., Peltola, H., Nors, T., Haque, H., and Makela, P.H., 1977, Adverse reactions and endotoxin content of Polysaccharide vaccines, Dev. Biol. Stand. 34:117–125.
Lepow, M.L., Goldschneider, I., Gold, R., Randolph, M., and Gotschlich, E.C., 1977, Persistence of antibody following immunization of children with groups A and C meningococcal Polysaccharide vaccines, Pediatrics 60:673–680.
Lim, D., Gewurz, A., Lint, T.F., Ghaze, M., Sepheri, B., and Gewurz, H., 1976, Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis, J. Pediatr. 89:42–47.
Liu, T.Y., Gotschlich, E.C., Jonssen, E.K., and Wysocki, J.R., 1971a, Studies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A Polysaccharide, J. Biol. Chem. 246:2849–2858.
Liu, T.Y., Gotschlich, E.C., Dunne, F.T., and Jonssen, E.K., 1971b, Studies on the meningococcal Polysaccharides. II. Composition and chemical properties of the group B and C Polysaccharides, J. Biol. Chem. 246:4703–4712.
Makela, P.H., Kayhty, H., Weckstrom, P., Sivonen, A., and Renkonen, O.-V., 1975, Effect of group A meningococcal vaccine in Army recruits in Finland, Lancet 2:883–886.
Makela, P.H., Peltola, H., Kayhty, H., Jousimies, H., Pettay, O., Ruoslahti, E., Sivonen, A., and Renkonen, O.-V., 1977, Polysaccharide vaccines of group A Neisseria meningitidis and Haemophilus influenzae type b: A field trial in Finland, J. Infect. Dis. 136:S43–S50.
McCormick, J.B., Weaver, R.E., Thornsberry, C., and Feldman, R.A., 1974, Trends in disease caused by Neisseria meningitidis: 1972 and 1973, J. Infect. Dis. 130:212–214.
Meningococcal Surveillance Group, 1976, Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis, J. Infect. Dis. 134:201.
Millar, J.W., Siess, E.E., and Feldman, H.A., Silberman, C., and Frank, P., 1963, In vivo and in vitro resistance to sulfadiazine in strains of Neisseria meningitides, JAMA 186:139–141.
Monto, A.S., Brandt, B.L., and Artenstein, M.S., 1973, Response of children to Neisseria meningitidis Polysaccharide vaccines, J. Infect. Dis. 127:394–400.
Morbidity Mortality Weekly Report, 1975, Meningococcal Polysaccharide vaccines, Morbid. Mortal. Wkly. Rep. 25:381–382.
Morbidity Mortality Weekly Report, 1976, Reported morbidity and mortality in the United States, Morbid. Mortal. Wkly. Rep. 25(53):50.
Morbidity Mortality Weekly Report, 1977, Follow-up on meningococcal disease — Alaska, Oregon, Washington, Morbid. Mortal. Wkly. Rep. 26:101–102.
Munford, R.S., and Gorman, G.W., 1974, Serotyping Neisseria meningitidis, Lancet 2:177.
Munford, R.S., Taunay, A. de E., deMorais, J.S., Fraser, D.W., and Feldman, R.A., 1974, Spread of meningococcal infection within households, Lancet 1:1275–1278.
Munford, R.S., Patton, C.M., and Gorman, G.W., 1975, Epidemiological studies of antigens common to groups B and C Neisseria meningitidis, J. Infect. Dis. 131:286–290.
Nicholson, A., and Lepow, J. H., 1978, Role of complement in defense against N. meningiditis, Clin. Res. 26:525A.
Peltola, H., 1977, Group A meningococcal and Haemophilus influenzae type b capsular Polysaccharide vaccines in infants and children under school age, Ph.D. thesis, 72 pp., Helsinki, Finland.
Peltola, H., Makela, P.H., Kayhty, H., Jousimies, H., Herva, E., Hallstrom, H., Sivonen, A., Renkonen, O.-V., Pettay, O., Karanko, V., Ahvonen, P., and Sarna, S., 1977, Clinical efficacy of meningococcus group A capsular Polysaccharide vaccine in children 3 months to 5 years of age, N. Engl. J. Med. 297:686–691.
Petersen, B.H., Graham, J.A., and Brooks, G.E., 1976, Human deficiency of the eighth component of complement: The requirement for C8 for serum Neisseria gonorrhoeae bactericidal activity, J. Clin. Invest. 57:283–290.
Pfair, J. J., 1958, Meningococcal meningitis, in: Preventive Medicine in World War II, Vol. IV: Communicable Diseases Transmitted Chiefly through Respiratory and Alimentary Tracts (J. B. Coates, Jr., ed.), pp. 191–209, Office of the Surgeon General Department of the Army, Washington, D.C.
Relier, L.B., MacGregor, R.R., and Beaty, H.N., 1973, Bactericidal antibody after colonization with Neisseria meningitidis, J. Infect. Dis. 127:56–62.
Robbins, J.B., Schneerson, R., Glode, M.P., Vann, W., Schiffer, M.S., Liu, T.Y., Parke, J.C., and Huntley, C., 1975, Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria, J. Allergy Clin. Immunol. 56:141–151.
Roberts, R.B., 1970, The relationship between group A and C meningococcal Polysaccharides and serum opsonins in man, J. Exp. Med. 131:499–513.
Rosen, F.S., and Janeway, C.A., 1966, The gammaglobulins. III. The antibody deficiency syndromes, N. Engl. J. Med. 275:709–715, 769-775.
Seeler, R.A., Metzger, W., and Mufson, M.A., 1972, Diplococcus pneumoniae infections in children with sickle cell anemia, Am. J. Dis. Child. 123:8–10.
Taunay, A. de E., Galvao, P.A., deMorais, J.A., Gotschlich, E.C., and Feldman, R.A., 1974, Disease prevention by meningococcal serogroup C Polysaccharide vaccine in preschool children, Pediatr. Res. 8:429.
Vassiliades, P., Kanellakis, A., and Papadakis, J., 1969, Sulfadiazine-resistant group A meningococci isolated during the 1968 meningitis epidemic in Greece, J. Hyg. 67:279–288.
Wahdan, M.H., Rizk, F., El-Akkad, A.M., El-Ghoroury, A.A., Hablas, R., Girgis, N.I., Amer, A., Boctar, W., Sippel, J.E., Gotschlich, E.C., Triau, R., Sanborn, W.R., and Cvjetanovic, B., 1973, A controlled field trial of a serogroup A meningococcal Polysaccharide vaccine, Bull. WHO 48:667–673.
Weekly Epidemiological Record, 1975, Meningitis, Argentina, Wkly. Epidemiol. Rec. 50:161.
Weekly Epidemiological Record, 1976, Meningococcal meningitis, Wkly. Epidemiol. Rec. 51:333–334.
Whittle, H.C., and Greenwood, B.M., 1976, Meningococcal meningitis in the norther savannah of Africa, Trop. Doc. 6:99–104.
Whittle, H.C., Abdullahi, M.T., Fakunle, F.A., Greenwood, B.M., Bryceson, A.D.M., Parry, E.H.O., and Turk, J.L., 1973, Allergic complications of meningococcal disease. I. Clinical aspects, Br. Med. J. 2:733–737.
Winkestein, J.A., and Drachman, R.H., 1968, Deficiency of pneumococcal serum opsonizing activity in sicklecell disease. N. Engl. J. Med. 279:459–466.
Wong, H.H., Barrera, O., Sutton, A., May, J., Hochstein, D.H., Robbins, J.D., Robbins, J.B., Parkman, P.D., and Seligman, E.B., Jr., 1977, Standardization and control of meningococcal vaccines, group A and group C Polysaccharides, J. Biol. Stand. 5:197–215.
Wyle, F.A., Artenstein, M.S., Brandt, B.L., Tramont, E.C., Kasper, D.L., Altieri, P.L., Berman, S.L., and Lowenthal, L.P., 1972, Immunologic response of man to group B meningococcal Polysaccharide vaccines, J. Infect. Dis. 126:514–522.
Young, L.S., LaForce, F.M., Head, J.J., Feely, J.C., and Bennett, J.V., 1972, A simultaneous outbreak of meningococcal and influenzae infections, N. Engl. J. Med. 287:5–9.
Zollinger, W.D., Pennington, C.L., and Artenstein, M.S., 1974, Human antibody response to three meningococcal outer membrane antigens: Comparison by specific hemagglutination assays, Infect. Immun. 10:975–984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Publishing Corporation
About this chapter
Cite this chapter
Lepow, M.L., Gold, R. (1981). Immunology of Neisseria meningitidis . In: Nahmias, A.J., O’Reilly, R.J. (eds) Immunology of Human Infection. Comprehensive Immunology, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1009-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1009-9_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1011-2
Online ISBN: 978-1-4684-1009-9
eBook Packages: Springer Book Archive